Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 8, 2000 - Issue 3
Submit an article Journal homepage
62
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Behçet's disease in Japan and in Great Britain: a comparative study

M. Muhaya Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
,
S. Lightman Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
,
E. Ikeda Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
,
M. Mochizuki Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
,
B. Shaer Kurume University School of Medicine, Kurume, and Tokyo Medical Dental University, Tokyo, Japan
,
P. McCluskey Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
&
H.M.A. Towler Kurume University School of Medicine, Kurume, and Tokyo Medical Dental University, Tokyo, JapanCorrespondence [email protected]
 show all
Pages 141-148 | Published online: 08 Jul 2009

References

  • B ehcet' s H. Uber rezidivierende Aphthose, durch em n Virus verusachte Geschwure am Mund, am Auge Und an den genitalien. Dermatol Wochenschr 1937;36:1152–1157.
  • Ohno S: BD in the world. In: Lehner T, Barnes CG, editors. Recent Advances in BD. London: Royal Society of Medicine Services, 1986; 181–186.
  • Shilmizu T, Ehrilich GE, Inaba G, Hayashi K. Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 1979;8:223–260.
  • Nakae K, Masaki F, Hashimoto T, et al. Recent epidemiological features of BD in Japan. In: Godeau P, Wechsler B, editors. BD. Amsterdam: Elsevier, 1993.
  • Mishima S, Masuda K, Izawa Y, et al:BD in Japan: ophthalmologic aspects, Trans Am Ophthalmol Soc 1979;76: 225–279.
  • Mamo JG. The rate of visual loss in Behçee s disease. Arch Ophthalmol 1970;84:451–452.
  • BenEzra D, Cohen E. Treatment and visual prognosis in BD. Br J Ophthalmol 1986;70:589–592.
  • Towler HMA, Lightman SL. Visual prognosis in BD. Ocul Immunol Inflam 1993;1(3):249–254.
  • International Study Group for Behçet's disease. Criteria of Behget's disease. Lancet 199o:335:m78–m80.
  • Annual Report of the BD Research Committee of Japan, Health and Welfare of Japan, 1978; 16-17. Yazici H, Tuzun Y, Pazarli H, et al. Influence of age of onset and patient's sex on the prevalence and severity of Behçee s syndrome, Ann Rheum Dis 1984;43:83–89.
  • Foster CS, Baer JC, Raizman MB. Therapeutic responses to systemic immunosuppressive chemotherapy agents in patients with Behçee s syndrome affecting the eyes. Proceedings of the Fifth International Congress on BD, Rochester, MN, 1989. In: O'Duffy JD, Kokman E, editors. BD: Basic and Clinical Aspects. New York: M. Dekker, 1991; 581–588.
  • Colvard DM, Robertson DM, O'Duffy JD. The ocular manifestations of BD. Arch Ophthalmol 1977;95:1813–1817.
  • Matsumura N, Mizushima Y. Leucocyte movement and colchicine treatment in BD. Lancet 1975;2:813.
  • Hijikata K, Masuda K. Visual prognosis in BD; effects of cyclophosphamide and colchicine. Jpn J Ophthalmol 1978;22:506–519.
  • Aktilga E, Altac M, Muftuoglu A, et al. A double blind study of colchicine in BD. Haematologica (Budap) 1980; 65:399–402.
  • Demiroglu H, Ozcebe OI, Barista I, Dundar S, Eldem B. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet's disease: a randomised trial. Lancet 2000;355: 605–609.
  • Koga T, Yano T, Ichikawa Y, et al: Pulmonary infiltrates recovered by FK506 in a patient with BD. Chest 1993:104:309–311.
  • Foster CS, Baer J. Behcet's disease in America: ocular manifestations and response to treatment. Recent Advances in Uveitis. Proceedings of the Third International Symposium on Uveitis. Brussels, Belgium: Kugler Publishers, 1993; 185–189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.